Literature DB >> 3535159

Cellular localisation in placenta of placental type plasminogen activator inhibitor.

B Astedt, I Hägerstrand, I Lecander.   

Abstract

A specific plasminogen activator inhibitor is known to occur in placenta and in pregnancy plasma. Immunohistochemical methods with polyclonal and monoclonal antibodies against the inhibitor were used for its localisation in term placentas. Immunoreactive material was found in the trophoblastic epithelium. It was absent in the stroma of the chorion villi.

Mesh：

Substances：

Year:  1986        PMID： 3535159

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


  10 in total

1.  The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival.

Authors:  K M Dougherty; J M Pearson; A Y Yang; R J Westrick; M S Baker; D Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

2.  Expression of plasminogen activator inhibitor type 2 in normal and psoriatic epidermis.

Authors:  B Lyons-Giordano; D Loskutoff; C S Chen; G Lazarus; M Keeton; P J Jensen
Journal:  Histochemistry       Date:  1994-02

3.  Abnormal expression of plasminogen activator inhibitors in patients with gestational trophoblastic disease.

Authors:  A Estellés; S Grancha; J Gilabert; T Thinnes; M Chirivella; F España; J Aznar; D J Loskutoff
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

4.  Gingival crevicular fluid IL-6, tPA, PAI-2, albumin levels following initial periodontal treatment in chronic periodontitis patients with or without type 2 diabetes.

Authors:  Levent Kardeşler; Nurcan Buduneli; Sevki Çetinkalp; David Lappin; Denis F Kinane
Journal:  Inflamm Res       Date:  2010-09-17       Impact factor: 4.575

Review 5.  PAI-1 in tissue fibrosis.

Authors:  Asish K Ghosh; Douglas E Vaughan
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

6.  Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor.

Authors:  T M Antalis; M A Clark; T Barnes; P R Lehrbach; P L Devine; G Schevzov; N H Goss; R W Stephens; P Tolstoshev
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

7.  Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells.

Authors:  P H Jensen; E I Christensen; P Ebbesen; J Gliemann; P A Andreasen
Journal:  Cell Regul       Date:  1990-12

8.  Immunohistochemical localization of serine-protease inhibitors in the human placenta.

Authors:  M Castellucci; T Theelen; E Pompili; L Fumagalli; G De Renzis; J Mühlhauser
Journal:  Cell Tissue Res       Date:  1994-11       Impact factor: 5.249

9.  Spatiotemporal expression of the serine protease inhibitor, SERPINE2, in the mouse placenta and uterus during the estrous cycle, pregnancy, and lactation.

Authors:  Schu-Rern Chern; Sheng-Hsiang Li; Chung-Hao Lu; Edmund I Tsuen Chen
Journal:  Reprod Biol Endocrinol       Date:  2010-10-27       Impact factor: 5.211

10.  Gestational hemostasis: a natural model for hemostasis resuscitation of major periprocedural blood loss : "Look deep into nature, and then you will understand everything better." Albert Einstein.

Authors:  Barna Babik; Szilvia Kupcsulik; János Fazakas
Journal:  Perioper Med (Lond)       Date:  2021-12-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.